任意の製品分析
許可いただいた場合、プライバシーに配慮した限定的な分析を使用し、どのリサーチ経路が有効かを把握します。広告トラッカーやセッション録画は使用しません。この選択は設定で変更できます。詳しくは プライバシーポリシー.
Illinois Tool Works Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $74.9B |
|---|
| Revenue (ttm) | 16.6B |
|---|
| Net income (ttm) | 3.2B |
|---|
| EPS (ttm) | $11.2 |
|---|
| Shares out | 284.8M |
|---|
| P/E (trailing) | 24.7x |
|---|
| P/E (forward) | 21.9x |
|---|
| Dividend | $6.88 (2.50%) |
|---|
| Volume | 971,173 |
|---|
| Beta | 0.97 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $14.46B | $15.93B | $16.11B | $15.90B | $16.04B | +2.6% |
| Gross profit | $5.97B | $6.50B | $6.79B | $6.94B | $7.08B | +4.4% |
| Operating income | $3.48B | $3.79B | $4.04B | $4.26B | $4.22B | +4.9% |
| Net income | $2.69B | $3.03B | $2.96B | $3.49B | $3.07B | +3.3% |
| EPS (diluted) | $8.51 | $9.77 | $9.74 | $11.71 | $10.49 | +5.4% |
| EBITDA | $3.66B | $4.18B | $4.04B | $5.11B | $4.65B | +6.2% |
| R&D | $239.0M | $269.0M | $284.0M | $292.0M | $302.0M | +6.0% |
| SG&A | $2.36B | $2.58B | $2.62B | $2.68B | $2.78B | +4.2% |
Recent company headlines from major financial publishers.
Under the base path, ITW delivers disciplined operational execution across operating segments. Free cash flow conversion exceeds guided benchmarks, supporting dividend compounding and regular share repurchases. Discounted at the house cost of equity with normalized terminal valuation multiples, this yields the central Fair value of $195.02.
Global industrial demand accelerates across North America, EMEA, and Asia Pacific. Accelerated adoption of Customer-Back Innovation products expands market share while operational cell efficiencies deliver strong incremental margins. Free cash flow conversion exceeds net earnings, funding accelerated buybacks that expand diluted share compounding and lift intrinsic valuation toward Potential value of $222.75.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.3% | $207 | $211 | $215 | $219 | $224 |
| 8.8% | $198 | $201 | $204 | $208 | $212 |
| 9.3% | $190 | $192 | $195 | $198 | $201 |
| 9.8% | $183 | $185 | $187 | $190 | $192 |
| 10.3% | $176 | $178 | $180 | $182 | $184 |
Upcoming earnings date and setup when available.
各月に公開されたリサーチ版が示したレーティングです。レーティングは分析時点の株価を公正価値と比較したもので、判断が当たったかどうかの記録ではありません。
| 年 | 1月 | 2月 | 3月 | 4月 | 5月 | 6月 | 7月 | 8月 | 9月 | 10月 | 11月 | 12月 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
